RegMedNet
Media & Internet · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2-4 Park Square Milton Park, Abingdon, O...Phone Number
+44 2083716090Website
www.regmednet.comRevenue
$6.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About RegMedNet
RegMedNet is a platform dedicated to regenerative medicine, providing news, expert insights, and research updates in advanced therapies. It serves as a resource for professionals in the field, covering topics such as cell therapy, gene editing, and tissue engineering. The platform is part of the Taylor & Francis Group, which enhances its credibility and reach within the scientific community. RegMedNet aims to connect researchers, clinicians, and industry stakeholders to foster collaboration and innovation in regenerative medicine.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RegMedNet your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
RegMedNet, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when RegMedNet launches new products
Click to see if RegMedNet had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if RegMedNet has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on RegMedNet recently announced quarterly report
Funding: Get notified immidiatlly once RegMedNet has new funding data
Check out if RegMedNet is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at RegMedNet
Recommended Actions
Reach out to Masked Content who joined RegMedNet as Masked Content
Find 3 more new buyers
Compare Similar Companies to RegMedNet
Compare insights from companies similar to RegMedNet, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
RegMedNet
$6.4M
1-10
Private
-
2005
N/A
Company Profile Activity
Activity Insights
RegMedNet is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
RegMedNet is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about RegMedNet.
RegMedNet Tech Stack
A closer look at the technologies used by RegMedNet
RegMedNet News & Media
Cell therapy weekly: Leveraging CRISPR-Cas3 to treat epidermolysis bullosa - RegMedNet
In this week's round-up: Healiva (Lugano, Switzerland) and C4U Corporation (Osaka, Japan) have formed a strategic alliance to develop CRISPR-Cas3-based gene therapy for epidermolysis bullosa.Cell therapy weekly: ImmuneBridge raises US$12 million in seed financing - RegMedNet
This week: catch up on top news from funding to FDA licence applications!Cell therapy weekly: Gamida Cell closes US$25 million financing - RegMedNet
This week in cell therapy weekly: license agreements, manufacturing collaborations and more! Get all the latest news on RegMedNet.com.
Read more news
Top Media & Internet Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RegMedNet
Sign Up For FreeTo access detailed company insights
RegMedNet is a platform dedicated to regenerative medicine, providing news, expert insights, and research updates in advanced therapies. It serves as a resource for professionals in the field, covering topics such as cell therapy, gene editing, and tissue engineering. The platform is part of the Taylor & Francis Group, which enhances its credibilit... Read More
